A tragic paradox, Gilead updates, and lots of Pfizer news
Adam Feuerstein/Stat Matthew Herper covers medical innovation — each its promise and its perils.Adam Feuerstein is a senior author and ...
Adam Feuerstein/Stat Matthew Herper covers medical innovation — each its promise and its perils.Adam Feuerstein is a senior author and ...
Pfizer’s high most cancers medication are small molecules, however dealmaking has expanded the pharmaceutical big’s portfolio and pipeline with biologic ...
Camosun Faculty / Flickr cc A examine revealed earlier this week in Nature Communications utilizing claims information from the US ...
Pfizer on Thursday made vital modifications to its range, fairness, and inclusion webpage, as corporations throughout completely different industries search ...
Pfizer agreed to pay practically $60 million to resolve allegations that its Biohaven Prescription drugs unit paid kickbacks to entice ...
Pfizer Chairman and CEO Albert Bourla didn't mince his phrases on the forty third annual J.P. Morgan Healthcare Convention in ...
Pfizer’s analysis partnership with Sangamo Therapeutics produced a hemophilia A gene remedy that reached FDA discussions a couple of regulatory ...
Pfizer mentioned its chief oncology officer, Chris Boshoff, will head all the firm’s analysis and improvement efforts along with holding ...
She knew what it was to have ache she couldn’t put into phrases, however this was worse. As a toddler, ...
This story first appeared in The Readout publication. Join The Readout and obtain STAT’s award-winning biotech information delivered straight to your inbox. Good morning. ...
Credit score: Unsplash/CC0 Public Area A number of the most dangerous genetic modifications in most cancers are additionally the toughest...
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.